Harsh Trivedi, M.D., MBA, associate professor of Psychiatry, vice chair for Clinical Affairs for Vanderbilt’s Department of Psychiatry, and executive director and chief medical officer of Vanderbilt Behavioral Health, has been selected to serve on the American Hospital Association’s Governing Council on Psychiatric and Substance Abuse Services.

Schizophrenia and bipolar disorder share common genetic underpinnings. Vanderbilt researchers combined high-resolution gene expression studies with gene association data to reveal signaling pathways linked to schizophrenia and bipolar disorder.

Stephan Heckers, M.D., M.Sc., William P. and Henry B. Test Professor of Schizophrenia Research and chair of the Department of Psychiatry, has been named the next editor-in-chief of JAMA Psychiatry, one of nine specialty journals in the JAMA Network.

It may be possible to use skin cells as biomarkers to diagnose and manage depression.

A retrospective analysis of Tennessee physicians who underwent fitness-for-duty evaluations by Vanderbilt found an “astoundingly” high rate of suicide among physicians who were found unfit to practice, were in solo practice, or if they were taking anti-anxiety drugs.

Vanderbilt investigators have constructed a network map that could guide the development of new targeted cancer therapies.

Augmenting the signals of natural “endocannabinoids” in the brain may be a promising approach for treating mood and anxiety disorders.